R. Kirchmair

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R Kirchmair, R. Kirchmair, Rudolph Kirchmair, Rudolf Kirchmair
Publication record
161 papers · 7,442 citations · H-index 47

PAPERS

Machine Learning Based Multi-Parameter Modeling for Prediction of Post-Inflammatory Lung Changes
20251 citationsauthor #13
Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression
202313 citationsauthor #7
The angiogenic neuropeptide catestatin exerts beneficial effects on human coronary vascular cells and cardiomyocytes.
20234 citationsauthor #7
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
20230 citationsauthor #43
Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular disease
202335 citationsauthor #13
Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
202318 citationsauthor #32
Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound
20235 citationsauthor #7
Correlation of cholesterol efflux capacity with femoral and carotid plaque volume measured by sonographic 3D plaque volumetry
20220 citationsauthor #8
Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study
202291 citationsauthor #15
Beneficial effects of multi-disciplinary rehabilitation in post-acute COVID-19 - an observational cohort study.
2021131 citationsauthor #3
Effect of chronic kidney disease and sex on carotid and femoral plaque volume as measured by three-dimensional ultrasound.
20213 citationsauthor #6
High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasound
20218 citationsauthor #7
miR-19a-3p containing exosomes improve function of ischemic myocardium upon shock wave therapy.
202097 citationsauthor #22
NGAL Correlates with Femoral and Carotid Plaque Volume Assessed by Sonographic 3D Plaque Volumetry
20207 citationsauthor #5
Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound
20207 citationsauthor #6
Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial
2020388 citationsauthor #39
Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression.
202017 citationsauthor #8
A Large Bifurcation Angle Is Strongly Associated With Increased Plaque Volume and Plaque Progression.
20198 citationsauthor #7
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
201938 citationsauthor #15
Driving ability after right-sided puncture of the common femoral artery during coronary angiography
20181 citationsauthor #4
P1541Plasma levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with carotid artery plaque volume - A new biomarker in preventive cardiology?
20180 citationsauthor #5
Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy
201810 citationsauthor #9
Shock Wave Therapy Improves Cardiac Function in a Model of Chronic Ischemic Heart Failure: Evidence for a Mechanism Involving VEGF Signaling and the Extracellular Matrix
201833 citationsauthor #17
Influence of Traditional Cardiovascular Risk Factors on Carotid and Femoral Atherosclerotic Plaque Volume as Measured by Three-Dimensional Ultrasound
201821 citationsauthor #7
Femoral access site closure without prior femoral angiography
20181 citationsauthor #5
P2618Geometric factors, particularly a large bifurcation angle determine atherosclerotic development and progression in patients with subclinical carotid atherosclerosis
20180 citationsauthor #7
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
2017133 citationsauthor #19
miR-19a-3p Containing Exosomes Improve Cardiac Function in Ischemic Myocardium
20171 citationsauthor #9
Nilotinib-induced vasculopathy : identification of vascular 1 endothelial cells as a primary target site 2 3 4
20170 citationsauthor #19
Secretogranin II: Novel Insights into Expression and Function of the Precursor of the Neuropeptide Secretoneurin
20170 citationsauthor #3
Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML.
201766 citationsauthor #7
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model
201724 citationsauthor #10
Granin-derived peptides.
201764 citationsauthor #3
P2557Combined transplantation of mesenchymal stem cells with secretoneurin improves heart function and prevents negative remodelling in acute myocardial infarction
20170 citationsauthor #10
Anticoagulation with rivaroxaban after ultrasound-assisted catheter-directed thrombolysis in patients with intermediate highrisk pulmonary embolism a case series
20165 citationsauthor #3
Epicardial shock‐wave therapy improves ventricular function in a porcine model of ischaemic heart disease
201642 citationsauthor #12
Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
201644 citationsauthor #8
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.
201658 citationsauthor #14
Ponatinib Exerts Multiple Effects on Vascular Endothelial Cells: Possible Mechanisms and Explanations for the Adverse Vascular Events Seen in CML Patients Treated with Ponatinib
201612 citationsauthor #2
Angiologische Grenzentscheidungen: Antikoagulation bei distaler Thrombose beziehungsweise subsegmentaler Pulmonalarterienembolie // Borderline Decisions in Angiology: Anticoagulation in Distal Thrombosis and Subsegmental Pulmonary Embolism
20160 citationsauthor #2
Ponatinib augments vasoconstriction and attenuates vasorelaxation in mouse aortic rings
20162 citationsauthor #2
Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapy.
201522 citationsauthor #4
Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI
201522 citationsauthor #6
Added Sugar, Macro- and Micronutrient Intakes and Anthropometry of Children in a Developing World Context
201532 citationsauthor #6
Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age‐related macular degeneration: a randomised, prospective trial
201597 citationsauthor #6
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
201516 citationsauthor #13
Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation
201437 citationsauthor #6
Erratum to: Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation
20140 citationsauthor #6
Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib on Endothelial Cells: A Potential Mechanism to Explain Vasculopathies in Cml Patients Treated With Nilotinib
20140 citationsauthor #20
Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome plus CML
20146 citationsauthor #20
Analysis of Volatile Organic Compounds Liberated and Metabolised by Human Umbilical Vein Endothelial Cells (HUVEC) In Vitro
20143 citationsauthor #5
Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CML
20140 citationsauthor #20
Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation
201454 citationsauthor #11
Abstract 17225: Extracellular Signal-Regulated Kinase 1/2 is Essential for Lipocalin-2 Signaling in Endothelial Cells
20140 citationsauthor #7
Systemic upregulation of PDGF-B in patients with neovascular AMD.
201432 citationsauthor #2
Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
201455 citationsauthor #7
Abstract 15828: Preserved Efficacy of Secretoneurin Gene Therapy in Hypercholesterolemia
20140 citationsauthor #1
Analysis of Volatile Organic Compounds Liberated and Metabolised by Human Umbilical Vein Endothelial Cells (HUVEC) In Vitro
201421 citationsauthor #5
Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy
201335 citationsauthor #2
Medical therapy for peripheral vascular disease
20130 citationsauthor #1
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
201394 citationsauthor #9
Direct epicardial shock wave therapy improves ventricular function in a porcine model of ischemic heart disease: evidence for induction of angiogenesis and stimulation of VEGF receptors
20131 citationsauthor #8
Abstract 18112: Low-Energy Shock Wave Treatment Induces Angiogenesis in Ischemic Muscle by Stimulation of Toll-Like Receptor 3 Signaling
20130 citationsauthor #6
Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF
201322 citationsauthor #9
Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML
201348 citationsauthor #17
Abstract 13269: The Tyrosine Kinase Inhibitor Nilotinib Induces Vascular Adverse Events in Patients With Chronic Myeloid Leukemia and Inhibits Endothelial Function and Angiogenesis
20130 citationsauthor #1
Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization
201322 citationsauthor #8
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema
2013159 citationsauthor #2
Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF
20133 citationsauthor #9
Vascular Endothelial Growth Factor in Plasma of Patients with ARMD after Intravitreal Injection of Bevacizumab, Ranibizumab and Pegaptanib
20120 citationsauthor #4
Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice.
201210 citationsauthor #9
Vanin-1 Pantetheinase Drives Smooth Muscle Cell Activation in Post-Arterial Injury Neointimal Hyperplasia
201240 citationsauthor #4
Tuesday, 28 August 2012
20121 citationsauthor #4960
An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
201226 citationsauthor #6
The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells
2012106 citationsauthor #19
Infarction by Stimulation of VEGF Signaling in Endothelial Cells The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial
20120 citationsauthor #2
The angiogenic factor secretoneurin activates VEGFR2 in coronary endothelial cells by operating as endogenous stimulator of VEGF binding to heparansulfate proteoglycans
20120 citationsauthor #1
An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
20124 citationsauthor #6
Abstract 18374: Secretoneurin Gene Therapy Improves Hindlimb and Cardiac Ischemia in Apo E -/- mice Without Influencing Systemic Atherosclerosis
20120 citationsauthor #8
Gene Therapy for Therapeutic Angiogenesis
20111 citationsauthor #1
Abstract 20102: The Neuropeptide Catestatin acts as an Angiogenic Factor via Basic Fibroblast Growth Factor Signaling
20100 citationsauthor #7
Abstract 19194: Gene Therapy with the Angiogenic Factor Secretoneurin Improves Nerve Function in Diabetic Neuropathy
20100 citationsauthor #1
Saturday, 17 July 2010
20100 citationsauthor #12
Sunday, 18 July 2010
20100 citationsauthor #273
The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism
201096 citationsauthor #15
Abstract 5138: Secretoneurin Therapy Improves Cardiac Function in a Model of Myocardial Infarction in-vivo and Induces Angiogenesis and VEGF Expression in Cardiac Cells in-vitro
20090 citationsauthor #16
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: A randomized, double‐blinded trial
2009105 citationsauthor #11
Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide–Dependent Mechanism
200953 citationsauthor #21
Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study.
200959 citationsauthor #3
Abstract 5586: Catestatin Induces Therapeutic Neovascularization by Induction of Angiogenesis and Incorporation of Endothelial Progenitor Cells
20090 citationsauthor #11
Monocyte migration: a novel effect and signaling pathways of catestatin.
200888 citationsauthor #14
Chromogranin B and Secretogranin II in Transgenic Mice Overexpressing Human APP751 with the London (V717I) and Swedish (K670M/N671L) Mutations and in Alzheimer Patients
200812 citationsauthor #7
Conditional knockout of the secretogranin II gene to reveal biological functions of secretoneurin
20082 citationsauthor #2
Images in cardiovascular medicine. Malicious licorice.
20085 citationsauthor #4
The novel angiogenic cytokine secretoneurin promotes angiogenesis, arteriogenesis and vasculogenesis in the mouse hind-limb ischemia model
20080 citationsauthor #13
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF.
200785 citationsauthor #1
Abstract 229: The Novel Angiogenic Cytokine Secretoneurin promotes Angiogenesis, Arteriogenesis and Vasculogenesis in the Hind-Limb Ischemia Model
20070 citationsauthor #10
Hypoxia up‐regulates the angiogenic cytokine secretoneurin via an HIF‐1α‐ and basic FGF‐dependent pathway in muscle cells
200772 citationsauthor #20
Postprandial, but not postabsorptive low-density lipoproteins increase the expression of intercellular adhesion molecule-1 in human aortic endothelial cells.
200613 citationsauthor #3
Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.
200641 citationsauthor #6

TIMELINE

1992 48 citations

1993 387 citations

1994 155 citations

1995 490 citations

1996 45 citations

1997 67 citations

1998 56 citations

1999 0 citations

2000 51 citations

2001 240 citations

2002 1,190 citations

2003 359 citations

2004 893 citations

2005 478 citations

2006 54 citations

2007 157 citations

2008 107 citations

2009 217 citations

2010 96 citations

2011 1 citations

2012 187 citations

2013 384 citations

2014 208 citations

2015 189 citations

2016 163 citations

2017 288 citations

2018 66 citations

2019 46 citations

2020 516 citations

2021 142 citations

2022 91 citations

2023 75 citations

2025 1 citations

Unknown 0 citations

R. Kirchmair

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT